Yuheng Pang

Harbin, 150000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Immune-metabolic profiling of triple-negative breast cancer during neoadjuvant chemotherapy.

Immune-metabolic profiling of triple-negative breast cancer during neoadjuvant chemotherapy.

Journal: iScience

Published: November 13, 2025

Application of mass cytometry in the immune microenvironment of breast cancer.

Application of mass cytometry in the immune microenvironment of breast cancer.

Journal: Medical oncology (Northwood, London, England)

Published: February 08, 2025

Activated platelets stimulate effector CD8+ T cells to enhance HNSCC immunotherapy efficacy.

Activated platelets stimulate effector CD8+ T cells to enhance HNSCC immunotherapy efficacy.

Journal: Discover oncology

Published: November 29, 2024

Rosmarinic acid promotes mitochondrial fission and induces ferroptosis in triple-negative breast cancer cells.

Rosmarinic acid promotes mitochondrial fission and induces ferroptosis in triple-negative breast cancer cells.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: October 22, 2024

Caffeic acid inhibits the tumorigenicity of triple-negative breast cancer cells through the FOXO1/FIS pathway.

Caffeic acid inhibits the tumorigenicity of triple-negative breast cancer cells through the FOXO1/FIS pathway.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: May 13, 2024

CyTOF analysis revealed platelet heterogeneity in breast cancer patients received T-DM1 treatment.

CyTOF analysis revealed platelet heterogeneity in breast cancer patients received T-DM1 treatment.

Journal: Clinical immunology (Orlando, Fla.)

Published: January 14, 2024

The combination of the HDAC1 inhibitor SAHA and doxorubicin has synergic efficacy in triple negative breast cancer in vivo.

The combination of the HDAC1 inhibitor SAHA and doxorubicin has synergic efficacy in triple negative breast cancer in vivo.

Journal: Pharmacological research

Published: July 11, 2023

Cancer stem cells promote lymph nodes metastasis of breast cancer by reprogramming tumor microenvironment.

Cancer stem cells promote lymph nodes metastasis of breast cancer by reprogramming tumor microenvironment.

Journal: Translational oncology

Published: April 28, 2023

Highly-tumor-targeted PAD4 inhibitors with PBA modification inhibit tumors in vivo by specifically inhibiting the PAD4-H3cit-NETs pathway in neutrophils.

Highly-tumor-targeted PAD4 inhibitors with PBA modification inhibit tumors in vivo by specifically inhibiting the PAD4-H3cit-NETs pathway in neutrophils.

Journal: European journal of medicinal chemistry

Published: April 03, 2023

Targeting mitochondrial dynamics by AZD5363 in triple-negative breast cancer MDA-MB-231 cell-derived spheres.

Targeting mitochondrial dynamics by AZD5363 in triple-negative breast cancer MDA-MB-231 cell-derived spheres.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: February 01, 2023

Genistein-induced mitochondrial dysfunction and FOXO3a/PUMA expression in non-small lung cancer cells.

Genistein-induced mitochondrial dysfunction and FOXO3a/PUMA expression in non-small lung cancer cells.

Journal: Pharmaceutical biology

Published: October 06, 2022

Single-Cell Proteomic Profiling Identifies Nanoparticle Enhanced Therapy for Triple Negative Breast Cancer Stem Cells.

Single-Cell Proteomic Profiling Identifies Nanoparticle Enhanced Therapy for Triple Negative Breast Cancer Stem Cells.

Journal: Cells

Published: August 30, 2021

Showing 1-12 of 12

Last Updated: 09/26/2026